Abstract
A new study using human pluripotent stem cell (hPSC)-derived human pancreatic organoids to model neoplastic transformation and cancer-derived human pancreatic tumor organoids for drug testing provides new personalized approaches to modeling and treating this malignancy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have